BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 23527602)

  • 1. Wiskott-Aldrich syndrome: a comprehensive review.
    Massaad MJ; Ramesh N; Geha RS
    Ann N Y Acad Sci; 2013 May; 1285():26-43. PubMed ID: 23527602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
    Snapper SB; Rosen FS
    Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wiskott-Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment.
    Ochs HD; Filipovich AH; Veys P; Cowan MJ; Kapoor N
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):84-90. PubMed ID: 19147084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wiskott-Aldrich syndrome.
    Ochs HD; Thrasher AJ
    J Allergy Clin Immunol; 2006 Apr; 117(4):725-38; quiz 739. PubMed ID: 16630926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
    Blundell MP; Worth A; Bouma G; Thrasher AJ
    Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genotype of the original Wiskott phenotype.
    Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
    N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
    Lemahieu V; Gastier JM; Francke U
    Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of the Wiskott-Aldrich syndrome.
    Rengan R; Ochs HD
    Rev Immunogenet; 2000; 2(2):243-55. PubMed ID: 11258421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel termination codon mutation of the WAS gene in a Thai family with Wiskott-Aldrich syndrome.
    Chatchatee P; Srichomthong C; Chewatavorn A; Shotelersuk V
    Int J Mol Med; 2003 Dec; 12(6):939-41. PubMed ID: 14612970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wiskott-Aldrich syndrome; an x-linked primary immunodeficiency disease with unique and characteristic features.
    Ariga T
    Allergol Int; 2012 Jun; 61(2):183-9. PubMed ID: 22361515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the biology of Wiskott-Aldrich syndrome (WAS).
    Thrasher AJ
    Hematology Am Soc Hematol Educ Program; 2009; ():132-8. PubMed ID: 20008191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mutation analysis of WASP gene and prenatal diagnosis of Wiskott-Aldrich syndrome].
    Liu N; Shi H; Kong X; Wu Q; Xu X; Bai Q; Feng Y; Zhao Z
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):662-6. PubMed ID: 25476427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of WASP mutations in 10 Australian families with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Bourne HC; Weston S; Prasad M; Edkins E; Benson EM
    Pathology; 2004 Jun; 36(3):262-4. PubMed ID: 15203732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wiskott-Aldrich syndrome.
    Ochs HD
    Semin Hematol; 1998 Oct; 35(4):332-45. PubMed ID: 9801262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human Wiskott-Aldrich syndrome protein in patients' cells leads to partial correction of a phenotypic abnormality of cell surface glycoproteins.
    Huang MM; Tsuboi S; Wong A; Yu XJ; Oh-Eda M; Derry JM; Francke U; Fukuda M; Weinberg KI; Kohn DB
    Gene Ther; 2000 Feb; 7(4):314-20. PubMed ID: 10694812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of six novel mutations in WASP gene in fifteen Iranian Wiskott-Aldrich patients.
    Safaei S; Fazlollahi MR; Houshmand M; Hamidieh AA; Bemanian MH; Alavi S; Mousavi F; Pourpak Z; Moin M
    Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):345-8. PubMed ID: 23264413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.